Comparison Chart Immunome, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 01:51:16 2024-06-28 pm EDT			5-day change	1st Jan Change
11.81 ^USD	-1.34%		-5.06%	+10.37%

Jun. 27	Immunome, Inc. Appoints Phil Tsai as Chief Technical Officer	CI
Jun. 24	Immunome, Inc.(NasdaqCM:IMNM) added to S&P Biotechnology Select Industry Index	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	IMMUNOME, INC.	Bio Therapeutic Drugs	-1.34%	-5.06%	+10.37%	+99.83%	-	718M